Is Lunai Bioworks Inc. (LNAI) overvalued at $12.4M cap?

Lunai Bioworks Inc. (LNAI) $12.4M cap.

Is this a short call on LNAI?

No. A rich cached multiple is not a short thesis.

Lunai Bioworks Inc. (LNAI) is a biotechnology company listed on NASDAQ.

This page asks whether Lunai Bioworks Inc. (LNAI) looks expensive on cached numbers — not a short thesis.

No cached income statement for LNAI, so there is no earnings base to call rich or cheap.

LNAI currently screens at market cap $12.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next LNAI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the LNAI stock page for the full model, not this heading.

Not investment advice.